Press Releases

Croissy-Beaubourg, September 23, 2020, 5:45pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announces that its half-year financial report as at 30 June 2020 has been…

Croissy-Beaubourg (77), September 21, 2020, 5:45 pm CEST - Theradiag, a French company specializing in diagnostic tests for autoimmune and infectious diseases, today announces the market launch of a CE-marked antigen test for detecting COVID-19.On…

·         Robust resilience in revenues at €4.9 million driven by Theranostic up +16.5% ·        Continued investment in R&D to drive future growth  ·        North America business accelerates ·        Sound cash position at €1.7 million ·        Launch…